Investor directory

Lumira Ventures

Founded in Toronto in 2007, Lumira Ventures is a venture capital firm focusing on investments in biotechnology, biopharmaceuticals, medical devices, digital health, and consumer health companies. With offices across North America, the firm invests primarily in Canada and the United States, typically allocating between USD 5 million to USD 15 million per investment. Lumira Ventures actively supports its portfolio companies by facilitating access to funding sources, partners, and market opportunities.
https://www.lumiraventures.com/
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=622128
https://www.privateequityinternational.com/database/#/profile?id=6587

Gerry Brunk

Managing Director

Baye Galligan

Director of Research

Daniel Hétu MD

Managing Director

Jacki Jenuth Ph.D

Partner

Vasco Larcina

CFO

Past deals in Vancouver

Zymeworks

Series A in 2016
Zymeworks is a biotechnology company focused on optimizing protein-based therapeutics, particularly for cancer treatment. It uses proprietary computational methods to engineer differentiated product candidates, with its lead asset zanidatamab in multiple clinical trials targeting HER2-expressing solid tumors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.